Gastrointestinal Stents Market Size, Share, and Forecast to 2035: Global Insights and Opportunities

The global Gastrointestinal Stents Market is poised for steady growth, valued at USD 540.1 million in 2025 and projected to reach USD 1.1 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.4%. This expansion is driven by the rising prevalence of gastrointestinal (GI) disorders, such as colorectal and esophageal cancers, increasing adoption of minimally invasive procedures, and advancements in stent technologies like biodegradable and drug-eluting stents. The market is further propelled by an aging population, changing lifestyles, and growing healthcare infrastructure in emerging economies.

Gastrointestinal stents are medical devices used to maintain patency in the GI tract, alleviating obstructions caused by cancers, strictures, or other disorders in areas like the esophagus, bile ducts, or colon. These stents, typically made of metal or plastic, enhance patient quality of life by reducing symptoms like pain and difficulty swallowing. Innovations such as self-expanding metal stents (SEMS) and bioabsorbable stents are transforming treatment outcomes.

For more insights, request a sample of this report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7694

Market Analysis

The gastrointestinal stents market is driven by the increasing incidence of GI cancers, with colorectal cancer causing 1.9 million new cases and 930,000 deaths globally in 2020, per WHO data. The aging population, projected to reach 1.6 billion people aged 65 and over by 2050, is more susceptible to GI disorders like diverticulosis and inflammatory bowel disease (IBD), boosting demand. Minimally invasive procedures, such as endoscopic stent placement, reduce recovery times and complications compared to traditional surgeries, driving adoption. Technological advancements, including nitinol-based SEMS and biodegradable stents, improve flexibility and reduce complications like stent migration. However, challenges include high procedure costs, averaging USD 43,798 per endoscopic stenting, limiting accessibility in developing regions. Limited reimbursement in countries like India and Brazil, risks of complications such as restenosis, and regulatory hurdles like FDA’s 510(k) requirements also restrain growth.

Segment Analysis

The gastrointestinal stents market is segmented by product, material, application, and end user. By product, biliary stents dominate, holding a 45% share in 2025, driven by the rising prevalence of bile duct cancer and gallstones, with sales projected to reach USD 500 million by 2035 at a 7.8% CAGR. Esophageal stents are the fastest-growing segment, with a CAGR of 8.5%, fueled by increasing esophageal cancer cases. By material, self-expanding metal stents (SEMS) lead with a 42.5% share due to their durability and ease of deployment, while bioabsorbable stents are gaining traction for reducing long-term complications. By application, biliary diseases hold the largest share, driven by their critical role in managing obstructions, while GI cancers, particularly colorectal, are growing rapidly. By end user, hospitals dominate due to advanced diagnostic tools and high procedure volumes, while ambulatory surgical centers are growing at a CAGR of 7.2% due to outpatient procedure trends.

Country-wise Insights

In the United States, the gastrointestinal stents market is valued at USD 194 million in 2025, with a projected CAGR of 7.0% through 2035, reaching USD 410 million. The U.S. leads due to high GI cancer prevalence, with 104,610 new colorectal cancer cases in 2020, and robust healthcare infrastructure. Favorable reimbursement policies and innovations from companies like Boston Scientific drive growth, though high costs and complications challenge smaller providers. North America holds a 43% market share. In the United Kingdom, the market is expected to grow at a CAGR of 6.8%, reaching USD 90 million by 2035.

Key Players

  • Boston Scientific Corporation
  • Cook Medical LLC
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Medtronic plc
  • Taewoong Medical Co., Ltd.

Strategic Outlook and Industry Trends

The gastrointestinal stents market is evolving through technological innovation and a focus on patient outcomes. The development of biodegradable and drug-eluting stents, like those from Cook Medical, reduces complications and enhances treatment efficacy. Minimally invasive procedures, supported by advancements in endoscopic techniques like EUS and ERCP, are increasing stent adoption. Strategic partnerships, such as Olympus’s distribution of MI-Tech’s HANAROSTENT in 2020, and product launches strengthen market positions. The growing focus on early diagnosis, driven by public health campaigns, boosts demand. Challenges include high costs, reimbursement limitations, and complications like stent migration. To sustain growth, companies must invest in R&D for cost-effective, advanced stents and expand into emerging markets with rising healthcare demands.

Segmentation of Gastrointestinal Stents Market

By Product:

    • Biliary Stents
    • Esophageal Stents
    • Colonic Stents
    • Pancreatic Stents
    • Duodenal Stents

By Material:

    • Self-Expanding Metal Stents (Nitinol, Stainless Steel, Others)
    • Plastic Stents
    • Bioabsorbable Stents

By Application:

    • Biliary Diseases
    • Gastrointestinal Cancers (Colorectal, Stomach, Esophageal, Pancreatic)
    • Inflammatory Bowel Disease
    • Others

By End User:

    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others

By Region:

    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • East Asia
    • South Asia & Pacific
    • Middle East & Africa

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

 

 

Comments

Post a Comment

Popular posts from this blog

Central Venous Catheters (CVCs) Market Size, Growth Opportunities, and Forecast to 2035

The global   Central Venous Catheters (CVCs) Market   is on a steady growth path, valued at USD 1.5 billion in 2025 and projected to reach USD 2.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.0%. This growth is fueled by the rising prevalence of chronic diseases such as cancer and kidney failure, increasing surgical procedures, and advancements in catheter technology. Central venous catheters are critical medical devices used for administering medications, fluids, nutrients, and monitoring hemodynamic status in critical care, oncology, and long-term treatment settings. The market’s expansion is further supported by the growing geriatric population and the increasing demand for minimally invasive procedures. The significance of this market lies in its essential role in modern healthcare, particularly for patients requiring long-term intravenous access. With an estimated 19.3 million new cancer cases globally in 2020 and chronic kidney disease affecting ...
Read more

Venous Procedure Devices Market Size, Share & Growth Outlook to 2035

The global   Venous Procedure Devices Market   is valued at approximately USD 2.2 billion in 2025 and is projected to surpass USD 4.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.4%. This growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in devices such as stents and catheters. The market is critical for addressing vascular conditions like deep vein thrombosis (DVT) and peripheral arterial disease (PAD), which affect millions globally, with the CDC estimating 900,000 annual DVT cases in the U.S. alone. The shift toward less invasive treatments and the growing adoption of advanced diagnostic tools are further propelling market expansion. The significance of this market lies in its role in improving patient outcomes through innovative devices that enable precise diagnostics and treatments. Venous procedure devices, including catheters, stents, and gu...
Read more

Novel Drug Delivery Systems (NDDS) Market Size, Share, Growth, Trends, and Forecast 2025-2035

The global   Novel Drug Delivery Systems (NDDS) Market   is set for substantial growth, valued at USD 89.7 billion in 2025 and projected to reach USD 172.9 billion by 2035, registering a compound annual growth rate (CAGR) of 6.8%. This growth is fueled by the rising demand for targeted, effective, and minimally invasive treatments for chronic diseases, oncology, and personalized medicine. The increasing focus on optimizing drug bioavailability, enhancing patient compliance, and minimizing side effects is revolutionizing drug delivery and formulation. NDDS encompasses advanced platforms such as transdermal patches, inhalers, liposomes, nanoparticles, implantable pumps, and microneedle systems, transforming therapeutic outcomes across various medical fields. The significance of this market lies in its ability to address critical challenges in traditional pharmacotherapy. With chronic diseases like cancer, diabetes, and cardiovascular conditions affecting millions globally—14.1 m...
Read more